The latest controversy surrounding Turkey’s military involves its most valued asset: conscripts. In the past month, nearly 2,000 cases of food poisoning have hit the Turkish Armed Forces (TSK). For much of last week, successive reports came out of five TSK units in Manisa province that 600 conscripts were hospitalized for severe nausea and vomiting. The incidents came in the wake of another bout in May, when more than 1,000 conscripts in Manisa sought treatment and Pvt. Husnu Ozel died because of food-borne illness.
The Turkish government has responded swiftly. Minister of National Defense Fikri Isik and Commander of the Land Forces Gen. Zeki Colak visited Manisa May 18. During the visit, Isik announced the cancellation of the contract with the company hired to prepare the soldiers’ food. The defense minister informed the Turkish parliament June 19 that he “will demand answers” for the incidents “even if [the offender] was his [brother].” As of June 19, 24 people have been detained in connection with the scandal.
The incident led to great outrage among Turks of all political stripes. Erkan Akcay, a member of parliament with the Nationalist Movement Party (MHP), which established a partnership with the ruling Justice and Development Party (AKP) after last year’s failed coup attempt, said the company also held lucrative contracts with other TSK units. He demanded to know which of the company’s contracts were canceled: only those with TSK installations in Manisa, where the majority of the poisoning cases happened, or all of them.
Tur Yildiz Bicer, a member of parliament with the Republican People’s Party (CHP) from Manisa, called for Isik’s resignation. Bicer and several CHP deputies claimed that the owners of the food service company in question were previously shielded from an investigation because of their connections to the ruling AKP. In addition, the CHP members claimed AKP and MHP deputies had refused to open a parliamentary investigation in the wake of the incident in May.
AL-MONITOR All-Access gives you unlimited access to all our journalism, the full Daily Briefing, exclusive interviews, premium newsletters, and live events — for less than $2/week.